BRAIN Biotech AG (LON:0RFI)
London flag London · Delayed Price · Currency is GBP · Price in EUR
2.550
-0.020 (-0.78%)
At close: Mar 27, 2026
Market Cap45.08M -3.4%
Revenue (ttm)42.75M -12.2%
Net Income-9.27M
EPS-0.43
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1
Average Volume506
Open2.560
Previous Close2.570
Day's Range2.550 - 2.560
52-Week Range1.810 - 3.900
Beta0.64
RSI53.17
Earnings DateMay 28, 2026

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bio... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 292
Stock Exchange London Stock Exchange
Ticker Symbol 0RFI

Financial Performance

In fiscal year 2025, BRAIN Biotech AG's revenue was 50.22 million, a decrease of -9.52% compared to the previous year's 55.50 million. Losses were -11.74 million, 5.53% more than in 2024.

Financial numbers in EUR Financial Statements